| Date | Title | | | 02/03/10 | OraSure CEO Appointed to Presidential Advisory Council on HIV/AIDS| BETHLEHEM, Pa., Feb 3, 2010 (GlobeNewswire via COMTEX) -- Douglas A. Michels, President and Chief Executive Officer of OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, was sworn in yesterday by U.S. Health and Human Services Secretary Kathleen Sebelius, as a new member of the Presidential Advisory Council on HIV/AIDS (PACHA).
PACHA provides advice, information, and recommendations to the President of the United States through the Secretary of Health and Huma... |
|  | | 01/28/10 | OraSure Technologies Earnings Conference Call Invitation| 2009 Fourth Quarter and Full Year Earnings Conference Call Wednesday, February 10, 2010, 5:00 p.m. ETBETHLEHEM, Pa., Jan 28, 2010 (GlobeNewswire via COMTEX) -- OraSure Technologies, Inc. (Nasdaq:OSUR) has scheduled its regular earnings conference call covering 2009 fourth quarter and full‑year financial results and certain 2010 financial guidance for 5:00 pm ET (2:00 pm PT) on Wednesday, February 10, 2010. An update on certain business developments will also be provided.
... |
| | | 01/19/10 | OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral Fluid Drugs of Abuse Assays| BETHLEHEM, Pa., Jan 19, 2010 (GlobeNewswire via COMTEX) -- OraSure Technologies, Inc. (Nasdaq:OSUR) and Roche Diagnostics today announced that the companies have signed an agreement for the worldwide commercialization of homogeneous fully automated oral fluid drugs of abuse assays with OraSure's Intercept(R) oral specimen collection device. The oral fluid assays use Roche's KIMS (kinetic interaction of micro-particles in solution) technology and are being jointly developed under an agreement pre... |
| | | 01/07/10 | OraSure Technologies Files Additional Data With FDA in Support of PMA Application for OraQuick Rapid HCV Test| BETHLEHEM, Pa., Jan 7, 2010 (GlobeNewswire via COMTEX) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today the recent filing of a pre-market approval ("PMA") amendment with the U.S. Food and Drug Administration ("FDA") for the Company's OraQuick(R) Rapid HCV Antibody Test. The amendment contains additional clinical data requested by the FDA for use of the test in detecting antibodies to the Hepatitis C Virus ("HCV") in venous whole blood samples.
When approved for use with venous whole... |
| | | 01/05/10 | OraSure Technologies to Participate at the Twelfth Annual Needham Growth Conference| BETHLEHEM, Pa., Jan 5, 2010 (GlobeNewswire via COMTEX) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Twelfth Annual Needham Growth Conference in New York at approximately 10:00 am Eastern Time (7:00 am Pacific Time) on Tuesday, January 12, 2010. The conference will be simultaneously webcast over the Internet.
Interested investors can access the live audio webcast of the d... |
| |
|
Print Page | 
E-mail Page | 
RSS Feeds | 
E-mail Alerts | 
IR Contacts | 
Financial Tear Sheet